Photo By Sgt. 1st Class Brent Powell | A group of 38 Army Reserve Soldiers fill out crew evaluation worksheets at the George W. Dunaway Reserve Center in Sloan, Nevada, Sept. 11 as part of a unique five-day Sabot Academy. The historic course is the first of its kind designed to prepare Soldiers to successfully complete the U.S. Army Reserve Command's Senior Gunner Course that will be unveiled early next year. (Official U.S. Army Reserve photo by Sgt. 1st Class Brent C. Powell) see less
| View Image Page
Attention unit G1s/S1s, please review the status of service members identified in eMILPO with COVID vaccine-related Assignment Consideration Codes (ASCO) of either L4 (Pending Exemption Action) or LE (Approved Vaccine Exemption).
Soldiers with an L4 code are not permitted to conduct a Permanent Change of Station. Soldiers with an LE code must have Under Secretary of the Army Approval to PCS in accordance with HQDA EXORD 225-21: COVID-19 Steady State Operations.
It is imperative that any Soldier who is fully vaccinated have their COVID ASCO removed in eMILPO as soon as possible.
In accordance with HQDA EXORD 225-21, an individual is considered fully vaccinated when at least 2 weeks have elapsed after a second dose of a two-dose COVID-19 vaccine series, or 2 weeks after receiving a single dose of a one-dose COVID-19 vaccine that are: (1) Fully licensed or authorized or approved by the FDA; (2) Listed for emergency use on the World Health Organization Emergency Use Listing; or (3) Approved for use in a clinical vaccine trial for which vaccine efficacy has been independently confirmed.
Please conduct this review and make the necessary update in eMILPO prior to start of the Brown Out/Cutover for IPPS-A scheduled to begin August 10, 2022.
This action will ensure the transfer of accurate data as we transition to the Integrated Personnel and Pay System – Army; support continued movement of Soldiers who are currently on assignment instructions; and support accurate strength projections to support readiness decision in the future.